R1 RCM Inc. is a leading provider of technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. R1's proven and scalable operating models seamlessly complement a healthcare organization's infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience.
Company profile
Website
CEO
Emad Rizk
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Accretive Health, Inc., R1 RCM INC.
SEC CIK
Corporate docs
Subsidiaries
Accretive Health Mauritius, Inc. • cGate Health, Inc. • Clearsight Intermediate Holdings, Inc. • Flare Capital Partners Investment Company • Intermedix ARM, LLC • Intermedix Corporation • Intermedix Holdings, Inc. • Intermedix Midco, Inc. • Intermedix Office Based, LLC • Intermedix Staffing, Inc. ...
IRS number
20698101
Latest filings (excl ownership)
15-12G
Securities registration termination
5 Jul 22
25-NSE
Exchange delisting
22 Jun 22
8-K
R1 Announces Grants of Inducement Equity Awards in Connection with the Acquisition of Cloudmed
21 Jun 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jun 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jun 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jun 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jun 22
POSASR
Automatic shelf registration (post-effective amendment)
21 Jun 22
8-K
Departure of Directors or Certain Officers
14 Jun 22
8-K
Submission of Matters to a Vote of Security Holders
2 Jun 22
Transcripts
Earnings call transcript
2022 Q1
9 May 22
Earnings call transcript
2021 Q4
17 Feb 22
Earnings call transcript
2021 Q3
2 Nov 21
Earnings call transcript
2021 Q2
4 Aug 21
Earnings call transcript
2021 Q1
8 May 21
Earnings call transcript
2020 Q4
18 Feb 21
Earnings call transcript
2020 Q3
3 Nov 20
Earnings call transcript
2020 Q2
4 Aug 20
Earnings call transcript
2020 Q1
6 May 20
Earnings call transcript
2019 Q4
20 Feb 20
Latest ownership filings
Financial summary
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 123.90 mm | 123.90 mm | 123.90 mm | 123.90 mm | 123.90 mm | 123.90 mm |
Cash burn (monthly) | 2.07 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 50.86 mm | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 73.04 mm | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 35.3 | n/a | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2023
8.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 1 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 5.69 bn |
Total shares | 461.16 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
King Luther Capital Management | 379.28 k | $5.69 bn |
Regis Management | 81.89 k | $1.23 mm |